Smith Group Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-50
| Closed | -$8K | – | 401 |
|
|
2021
Q2 | $8K | Hold |
50
| – | – | ﹤0.01% | 322 |
|
|
2021
Q1 | $9K | Sell |
50
-1,290
| -96% | -$232K | ﹤0.01% | 274 |
|
|
2020
Q4 | $294K | Hold |
1,340
| – | – | 0.02% | 161 |
|
|
2020
Q3 | $223K | Buy |
1,340
+410
| +44% | +$68.2K | 0.01% | 165 |
|
|
2020
Q2 | $106K | Sell |
930
-20
| -2% | -$2.28K | 0.01% | 192 |
|
|
2020
Q1 | $73K | Hold |
950
| – | – | ﹤0.01% | 230 |
|
|
2019
Q4 | $122K | Hold |
950
| – | – | 0.01% | 232 |
|
|
2019
Q3 | $74K | Buy |
+950
| New | +$74K | ﹤0.01% | 253 |
|